-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_research-protocol.pdf
April 01, 2013 - tumors are
considered potentially indolent.13 Although the primary measure of tumor aggressiveness … EMBASE (EMTREE)
Neoplasms/
Prostate/
Prostatic Neoplasms/
Cancer*
Carcinoma*
Neoplasm*
Prostat … Prostatic Neoplasms/
2 Prostate cancer (prostat$.ti,ab. or Prostate/) AND (cancer.ti,ab. or Neoplasms … /radiotherapy”[mesh]
2 Prostate cancer “prostatic neoplasms”[mesh] OR (prostat*[tiab] AND (neoplasm* … “prostate cancer” OR (prostat* AND (neoplasm* OR cancer* OR carcinoma*))
2 Treatment
options
“watchful
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
August 01, 2012 - [mh] OR neoplas* OR malignan* OR cancer OR
cancers OR cancerous OR tumor OR tumors OR tumour OR tumours … [mh] OR neoplas* OR malignan* OR cancer OR
cancers OR cancerous OR tumor OR tumors OR tumour OR tumours … [mh] OR neoplas* OR malignan* OR cancer OR cancers OR cancerous OR tumor OR tumors
OR tumour OR tumours … visit,
date of report of
cancer, or death
Development of a
neoplasm as
evidenced in medical
records … Recurrence of
pituitary or CNS
tumors was
reported in 6
(1.4%) patients;
recurrence of other
neoplasias
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
July 01, 2012 - 21
23 4 and 22
24 19 or 23
25 (chemoprevent$ adj3 (breast$ adj2 (neoplas$ or tumor$ or cancer$ … / or (breast$ adj2 (neoplas$ or tumor$ or cancer$ or malignan$)).mp.-
9-limit 8 to (english language … / or (breast$ adj2 (neoplas$ or tumor$ or cancer$ or malignan$)).mp.
2-tibolone.mp.
3-exp breast/ … / or (breast$ adj2 (neoplas$ or tumor$ or cancer$ or malignan$)).mp.
2-exp risk assessment/ or risk … / or (breast adj2 (cancer$ or tumor$ or malignan$ or carcino$ or neoplas$)).mp.
4-limit 3 to (english
-
effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies-update/research-protocol
December 01, 2019 - tumor grade in terms of the Gleason score, which ranges from 2 to 10. 4 Gleason 8–10 tumors are considered … tumors are considered potentially indolent. 13 Although the primary measure of tumor aggressiveness … EMBASE (EMTREE)
Neoplasms/
Prostate/
Prostatic Neoplasms/
Cancer*
Carcinoma* … or Neoplasms/ or neoplasm$ or carcinoma$)
3
Combine sets
S1 OR S2
4
Treatment options … “prostate cancer” OR (prostat* AND (neoplasm* OR cancer* OR carcinoma*))
2
Treatment options
-
effectivehealthcare-admin.ahrq.gov/health-topics/cancer?page=1
January 19, 2010 - These extra cells can form a mass called a tumor. Tumors can be benign or malignant. … Benign tumors aren't cancer while malignant ones are. … Cells from malignant tumors can invade nearby tissues. … There are more than 100 different types of cancer. Most cancers are named for where they start. … For example, lung cancer starts in the lung, and breast cancer starts in the breast.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
March 13, 2012 - Background
Stage II Colon Cancer
Colon cancer is a common malignancy affecting both women and … Stage II colon cancer is
characterized by full-thickness tumor invasion of the bowel wall and the absence … tumors that
directly penetrate to the surface of the visceral peritoneum), and IIC (T4b tumors where … Draft Search Strategy for Ovid MEDLINE
1. exp Colorectal Neoplasms/
2. … ((colorectal or colon$ or rectal or Sigmoid) adj3 (neoplasm$ or cancer$ or carcino$ or
tumo?
-
effectivehealthcare-admin.ahrq.gov/health-topics/lung-cancer
December 11, 2018 - Description
Lung cancer is one of the most common cancers in the world. … It is a leading cause of cancer death in men and women in the United States. … Cigarette smoking causes most lung cancers. … Targeted therapy uses substances that attack cancer cells without harming normal cells. … and Endobronchial Obstruction Due to Advanced Lung Tumors
Research Report December 20, 2011
-
effectivehealthcare-admin.ahrq.gov/products/skin-lesions-evaluation/research-protocol
December 01, 2019 - malignancies. … examine how these emerging non-invasive imaging modalities could be used to help diagnose cancerous tumors … whether or not patients have a history of other malignancies. … The rationale for this is the growing recognition of skin cancer as a leading form of second malignancy … Association of nonmelanoma skin cancer with second malignancy.
-
effectivehealthcare-admin.ahrq.gov/products/liver-cancer/research
December 01, 2019 - Structured Abstract
Objectives
Hepatocellular carcinoma (HCC) is the most common primary malignant … neoplasm of the liver, and accurate diagnosis and staging of HCC are important for guiding treatment … analyses were conducted to evaluate the effects of the reference standard used and study, patient, tumor … Protocol
Dec 20, 2024
Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer … https://effectivehealthcare.ahrq.gov/products/liver-cancer/research
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/diagnosis-and-treatment-of-non-muscle-invasive-bladder-cancer
November 01, 2020 - , cystoscopy, urine cytology, urine-based biomarkers, transurethral resection of bladder tumor (TURBT … How do tumor characteristics (stage, grade, multiplicity, size, molecular and genetic alterations) predict … perhaps replace cytology and cystoscopy in the diagnosis and surveillance of patients with urothelial cancers … Genetic and epidemiological evidence indicates that African Americans may have a more aggressive form of malignancy … for 90% of all malignant tumors.
-
effectivehealthcare-admin.ahrq.gov/products/bladder-cancer-non-muscle-invasive/research-protocol
December 01, 2020 - Stage 2 cancers are muscle-invasive, and higher stage cancers invade beyond the muscle layer into surrounding … . 7 As many as 70 percent of Non-MIBC tumors will recur after initial treatment, with a 10-20 percent … These include the stage of the cancer, tumor grade, whether the tumor is an initial tumor or a recurrence … and Treatment of Non-metastatic Muscle-invasive Bladder Cance r
exp Urinary Bladder Neoplasms/ … or 28 (215263)
7 and 29 (231)
9 or 11 or 20 or 22 or 24 or 26 or 30 (2005)
exp Urinary Bladder Neoplasms
-
effectivehealthcare-admin.ahrq.gov/products/bladder-cancer-muscle-invasive/research-protocol
December 01, 2020 - Stage 2 cancers are muscle-invasive, and higher stage cancers invade beyond the muscle layer into surrounding … Stage T4b cancer, in which the tumor has spread to the pelvis or abdominal wall, bladder cancer involving … Approximately 25 percent of newly diagnosed bladder cancers present as stage 2 or higher tumors. 6 Once … These include the stage of the cancer, tumor grade, whether the tumor is an initial tumor or a recurrence … and Treatment of Non-metastatic Muscle-invasive Bladder Cancer
exp Urinary Bladder Neoplasms/ (42649
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/liver-cancer_executive.pdf
October 01, 2014 - Executive Summary
Background and Objectives
Hepatocellular carcinoma (HCC) is
the most common primary malignant … neoplasm of the liver, usually developing
in individuals with chronic liver disease
or cirrhosis. … Worldwide, it is the fifth
most common cancer and the third most
common cause of cancer death.1 There … National Cancer Institute. Liver Cancer. www.cancer.gov/
cancertopics/types/liver. … SEER Cancer
Statistics Review, 1975-2010.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/liver-cancer-therapy_research-protocol.pdf
November 28, 2012 - Unlike most solid
tumors, the future incidence of and mortality rate due to HCC are projected to increase … using the following string of search terms:
"Carcinoma, Hepatocellular"[Mesh] OR (hepatocellular AND (neoplasm … * OR cancer OR
cancers OR carcinoma)) AND Unresectable OR nonresectable OR inoperable OR irresectable … comparative studies, and case
series by using the following string of search terms:
hepatocellular AND (neoplasm … * OR cancer OR cancers OR carcinoma) AND (unresectable OR
nonresectable OR inoperable OR irresectable
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
May 01, 2013 - One study reported cancer-free survival (from
time of study treatment to local tumor progression), extrahepatic … Authors varied in how these tumor characteristics
were described: mean number and size of tumors,
median … number and size of tumors, range of number
and size of tumors, percent solitary and nonsolitary
tumors … Hepatobiliary Cancers. Version 2. 2010. … Treatment of large and/
or multiple hepatic malignancies: open surgical approaches
of radiofrequency
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/bladder-cancer-muscle-invasive_research-protocol.pdf
July 21, 2014 - Stage 2 cancers are muscle-invasive, and higher stage cancers
invade beyond the muscle layer into surrounding … Stage T4b cancer, in which the tumor has spread to the pelvis or abdominal
wall, bladder cancer involving … Approximately 25 percent of newly diagnosed bladder cancers present as stage 2
or higher tumors.6 Once … These include the stage of the cancer, tumor grade, whether the tumor
is an initial tumor or a recurrence … and Treatment of Non-
metastatic Muscle-invasive Bladder Cancer
1. exp Urinary Bladder Neoplasms/
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rapid-response-chemotherapy-dental.pdf
July 01, 2023 - The cancer conditions included acute leukemias, clinically advanced multiple
myeloma, solid tumors with … Management of the
neck in early oral cancers: Is the verdict out? … potential dental focal infection
before the first cycle of chemotherapy in patients
with hematologic malignancy … searched: December 16, 2022
1 Bone Marrow Transplantation/ or exp Immunosuppression Therapy/ or exp Neoplasms … leukemia* or lymphom* or malig* or
neoplas* or onco* or radiat* or radiotherap* or "radio-therap*" or tumor
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
November 02, 2019 - non-dermatologic malignancy (174,650 new cases) and the second
leading cause of cancer death (31,620 … With AS, tumors are not
immediately removed, irradiated, or ablated.3, 4 Instead, tumors are monitored … Stage 1
T2= tumor Stage 2
T3= tumor Stage 3
T4= tumor Stage 4
WMD= weighted mean differences
WW … / (121506)
2 (prostat* and (neoplasm* or cancer* or carcinoma*)).ti,ab. (142514)
3 watchful … / (9241)
2 (prostat$.ti,ab. or Prostate/) and (cancer.ti,ab. or Neoplasms/ or neoplasm$.mp. or
-
effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-radiation/research
December 01, 2019 - outcomes, especially in higher risk tumors, although evidence is lacking. … Prior examinations of the same database have shown tumor characteristics such as size or stage to be … Higher doses of CRT are associated with lower tumor recurrence rates. … If CRT becomes less accessible, we may expect IMRT use to increase in other tumors, perhaps even in tumors … Monitoring IMRT use should be a priority for these other cancers as well as for groups of prostate cancer
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
August 23, 2010 - cancer in men and women, accounting
for nearly half of all malignancies. … examine how these emerging non-invasive
imaging modalities could be used to help diagnose cancerous tumors … whether or not patients have a
history of other malignancies. … The rationale for this is the growing recognition of skin cancer as
a leading form of second malignancy … Association
of nonmelanoma skin cancer with second malignancy. Cancer 2004 January
1;100(1):130-8.